Stay updated on Safety & Tolerability of MRT5005 in CF Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page.

Latest updates to the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page
- Check3 days agoChange Detectedv3.5.3 has been added to the revision history, replacing v3.5.2, reflecting an update to the page's release notes. The change appears to be an administrative update rather than a modification to substantive content or functionality.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedFooter now lists Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision on the page updated to v3.4.3, replacing v3.4.2. This appears as part of the site's versioning information.SummaryDifference0.0%

- Check82 days agoChange DetectedRESTORE-CF (NCT03375047) page updated to include Results Posted (Sanofi, 2026-02-09), 16 trial locations, and expanded details on study arms, dosing schedules, and primary/secondary outcomes.SummaryDifference7%

- Check89 days agoChange DetectedA site-wide funding-status notice now appears, indicating information may not be up to date due to a lapse in government funding. The footer revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Safety & Tolerability of MRT5005 in CF Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Tolerability of MRT5005 in CF Adults Clinical Trial page.